Nine Additional Ultrasound Innovators Join SAB to Provide Insights and Feedback to Further Improve the Company’s Technology Strategy

Kirkland, WA, July 13, 2023 – Verasonics, Inc., the leader in research ultrasound, announced today that it has expanded its Scientific Advisory Board (SAB) to include nine additional members with valuable expertise in the fields of biomedical engineering and Materials Science. These thought leaders will work closely with the Verasonics leadership team and existing SAB membership to provide external scientific review and insight on existing and emerging technologies, as well as potential research and development programs.

New members of the Scientific Advisory Board are as follows: individual bios can be found on the Verasonics website:

Pierre Belanger, PhD, Ecole de technologie supérieure (ETS) Montréal, Department of Mechanical Engineering Professor

Frederic Cegla, PhD, Imperial College London, Senior Lecturer & EPSRC Research Fellow in NDE

Hong Chen, PhD, Washington University, McKelvey School of Engineering, Associate Professor

Hyun Dongwoon, PhD, Stanford University, Radiology – Pediatric Radiology Instructor

Caterina Gallippi, PhD, Joint UNC, NCSU Department of Biomedical Engineering Professor

Joergen Jensen, PhD, Technical University of Denmark, Department of Health Technology Professor

Matt O’Donnell, PhD, University of Washington, Department of Bioengineering Professor

Jean Provost, PhD, Ecole Polytechnique de Montreal, Department of Engineering Physics, Associate Professor

Pengfei Song, PhD, University of Illinois, Electrical & Computer Engineering, Assistant Professor

“We are honored and privileged to expand our SAB to include this set of renowned and highly accomplished scientific experts,” said Jon K. Daigle, President and Chief Executive Officer at Verasonics. “Together, the SAB brings a broad spectrum of knowledge that will allow Verasonics
to leverage their depth of expertise to further advance research in ultrasound to better assist researchers and developers.”

Mr. Daigle added, “Our team would also like to thank Dr. James Greenleaf, Mayo Clinic, for his tremendous contributions to the SAB and Verasonics since 2018.” Dr. Greenleaf retired from the Verasonics SAB at the end of 2022.

About Verasonics, Inc.
Headquartered in Kirkland, Washington, USA, Verasonics is a privately held company founded in 2001. Verasonics, the leader in research ultrasound, empowers ultrasound innovation worldwide by providing flexible ultrasound platforms for research, development, and commercialization. Verasonics solutions are used across biomedical ultrasound, materials science, earth sciences, and acoustics to help accelerate innovation from concept to market. Verasonics also licenses its technology to companies for use in their commercial products.

Press Contact:
Verasonics
James Schada
+1 (425) 439-7235
[email protected]

Follow us: